Detalhe da pesquisa
1.
Intermittent fasting in the prevention and treatment of cancer.
CA Cancer J Clin
; 71(6): 527-546, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383300
2.
Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin.
Mol Cell Proteomics
; 22(1): 100476, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470535
3.
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Breast Cancer Res
; 25(1): 112, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784176
4.
The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Breast Cancer Res Treat
; 197(2): 319-331, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401732
5.
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment.
Future Oncol
; 19(8): 559-573, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070653
6.
CDK4/6 inhibition triggers anti-tumour immunity.
Nature
; 548(7668): 471-475, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813415
7.
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.
Breast Cancer Res Treat
; 189(1): 187-202, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34173924
8.
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
J Natl Compr Canc Netw
; : 1-8, 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761455
9.
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER+ breast cancer.
FASEB J
; 33(2): 1644-1657, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30161001
10.
Predictors of Distant Metastases in Triple-Negative Breast Cancer Without Pathologic Complete Response After Neoadjuvant Chemotherapy.
J Natl Compr Canc Netw
; 18(3): 288-296, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135512
11.
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?
Curr Oncol Rep
; 22(6): 57, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32415339
12.
Breast Cancer, HER2 Mutations, and Overcoming Drug Resistance.
N Engl J Med
; 385(13): 1241-1243, 2021 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551235
13.
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 174(2): 443-452, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604000
14.
Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer.
J Natl Compr Canc Netw
; 17(2): 141-147, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787127
15.
PI3K Inhibitors in Breast Cancer Therapy.
Curr Oncol Rep
; 21(12): 110, 2019 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31828441
16.
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer.
Breast Cancer Res Treat
; 169(3): 523-530, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29442264
17.
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
Breast Cancer Res Treat
; 170(3): 547-557, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29675680
18.
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Breast Cancer Res
; 19(1): 123, 2017 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29162134
19.
Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in US women 18 to 64 years old.
Cancer
; 123(16): 3125-3131, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440864
20.
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Breast Cancer Res Treat
; 161(3): 491-499, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27915434